For instance, efficacy of anti-CXCR4 ADCs did not correlate with antigen density on tumour cells: all cell lines with detectable surface CXCR4 demonstrated sensitivity to anti-CXCR4 ADCs. This evidence concerns the gene CXCR4 and neoplasm.